Literature DB >> 8113524

Treating periodontal diseases by blocking tissue-destructive enzymes.

L M Golub1, M Wolff, S Roberts, H M Lee, M Leung, G S Payonk.   

Abstract

A new therapeutic approach involves the discovery by the "Stony Brook group," that tetracyclines, but not other antibiotics, can inhibit host-derived collagen-destructive enzymes. This newly discovered property of tetracyclines is unrelated to the antimicrobial activity of these drugs. Examples support the hypothesis that this unexpected property of tetracyclines provides a new approach to treating periodontal diseases as well as a variety of medical disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113524     DOI: 10.14219/jada.archive.1994.0261

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  12 in total

1.  Iron-chelating activity of tetracyclines and its impact on the susceptibility of Actinobacillus actinomycetemcomitans to these antibiotics.

Authors:  D Grenier; M P Huot; D Mayrand
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues.

Authors:  T Imamura; K Matsushita; J Travis; J Potempa
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

3.  Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease.

Authors:  E H Burns; A M Marciel; J M Musser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 4.  Oral fluid-based biomarkers of alveolar bone loss in periodontitis.

Authors:  Janet S Kinney; Christoph A Ramseier; William V Giannobile
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

5.  The effect of laser irradiation and doxycycline application on the production of matrix metalloproteinase-8 and collagen I from cultured human periodontal ligament cells.

Authors:  Alireza Dehdashtizadeh; Nasim Esnaashari; Shirin Zahra Farhad; Fatemeh Ejeian; Shaharam Amini
Journal:  Dent Res J (Isfahan)       Date:  2020-05-23

6.  Triclosan blocks MMP-13 expression in hormone-stimulated osteoblasts.

Authors:  Virginia Monsul Barnes; Tao Xu; Emi Shimizu; Teruyo Nakatani; Steven Jefcoat; Anatoliy Vasilov; Ling Qin; Nicola C Partridge
Journal:  J Periodontol       Date:  2013-01-31       Impact factor: 6.993

7.  Multilevel analysis of clinical parameters in chronic periodontitis after root planing/scaling, surgery, and systemic and local antibiotics: 2-year results.

Authors:  Ibrahimu Mdala; Anne D Haffajee; Sigmund S Socransky; Birgitte Freiesleben de Blasio; Magne Thoresen; Ingar Olsen; J Max Goodson
Journal:  J Oral Microbiol       Date:  2012-04-24       Impact factor: 5.474

Review 8.  Periodontal therapeutics: Current host-modulation agents and future directions.

Authors:  Lorne M Golub; Hsi-Ming Lee
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 12.239

Review 9.  Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-23       Impact factor: 7.455

10.  Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs.

Authors:  Jie Deng; Lorne M Golub; Hsi-Ming Lee; Michael C Lin; Heta Dinesh Bhatt; Hou-Lin Hong; Francis Johnson; Joseph Scaduto; Thomas Zimmerman; Ying Gu
Journal:  J Exp Pharmacol       Date:  2020-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.